Presentation Archives

PART 1:  “New Options in the Treatment of Negative and Cognitive Symptoms in Schizophrenia” 

This talk was given in May 2012 to the Los Angeles chapter of the National Alliance for Mental Illness (NAMI).  It is archived here in four sections to make viewing convenient.

I have followed the research on NMDA Receptor dysfunction and its contribution to schizophrenia for over 15 years.   I routinely make use of the options discussed in this presentation, namely NAC and Sarcosine.

Section 1: Negative and Cognitive Symptoms of Schizophrenia

Section 2: The NMDA Receptor, Glycine and Glutamate

Section 3: Sarcosine – a Natural a Glycine Transporter Type 1 Inhibitor

Section 4: N-Acetyl Cysteine – an antioxidant precursor to Glutathione

PART 2:     “New Options in the Treatment of Negative and Cognitive Symptoms in Schizophrenia 

This talk was given in October 2012 to the Los Angeles chapter of the National Alliance for Mental Illness (NAMI).  It is archived here in four sections to make viewing convenient.

Section 1: Homocysteine, Folate and B12

Section 2: Celecoxib – a COX2 Inhibitor

Jeffrey Becker, MD, Private Practice Psychiatrist and UCLA/NPI Volunteer Clinical Faculty.

 

Comments are closed.